Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06624631 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

PDMC Implementation Trial in Kenya

Study acronym: PDMC-SL
StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2025 (before its estimated September 30, 2026 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Primary endpoints revised (2)
    • Interventions: Adherence support strategy a (Other), Adherence support strategy b (Other), Adherence support strategy c (Other) to Community Health Promoters (CHP) home visits; adherence support strategy b (Other), No reminders; adherence support strategy c (Other), SMS…
    v3
  2. Trial status: Not Yet Recruiting to Recruitingv2 Show 7 more changesShow less
    • Start date changed from estimate of Nov 2024 to Sep 5, 2025
    • Enrollment target: 712 to 600
    • Study sites: 0 to 1
    • Primary and study completion dates: Jun 2026 to Sep 30, 2026
    • Interventions: Delivery strategy A (Other), Delivery strategy B (Other) to Adherence support strategy a (Other), Adherence support strategy b (Other), Adherence support strategy c (Other)
    • Eligibility criteria revised
    • Study description expanded, about 29 words
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The goal of this implementation trial is to evaluate at least two alternative delivery strategies and adherence support for malaria chemoprevention with dihydroartemisinin-piperaquine in the post-discharge management of children hospitalised with severe anaemia or severe malaria to optimise adherence in Kenya. The actual interventions to be evaluated have been co-designed with national stakeholders during an initial formative research stage.
Trial Details
NCT Number NCT06624631
Lead Sponsor Liverpool School of Tropical Medicine
Collaborators: Kenya Medical Research Institute, Institut de Recherche Clinique du Benin, Epicentre, Paris, France and Mbarara University of Science and Technology, Faculty of Medicine, Mbarara, Uganda, Institute of Research for Development, France, Training Research Unit of Excellence, Blantyre, Malawi, Makerere University, Centres for Disease Control and Prevention, Kenya.
Conditions
(from sponsor)		 Severe Malaria, Severe Anemia
Related terms Anemia, Malaria
Enrollment 600 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov